B.N.Rathi Securities Ltd.

Company Profile

Smart Quotes

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti

BSE496.252.95 (+0.6 %)

PREV CLOSE ( ) 493.30

OPEN PRICE ( ) 489.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11051

TODAY'S LOW / HIGH ( )486.25 499.00

52 WK LOW / HIGH ( )408.95 645

NSE495.002.65 (+0.54 %)

PREV CLOSE( ) 492.35

OPEN PRICE ( ) 490.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 104914

TODAY'S LOW / HIGH( ) 485.55 499.10

52 WK LOW / HIGH ( )409 645.75

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-09 1984

Management Info

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office

Address Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone 022-24019025

Email investorrelations@aartidrugs.com

Website www.aartidrugs.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

28Aug Aarti Drugs informs about newspaper cl
Aarti Drugs has informed that the Post Buyback Public Announcement in co..

07Jul Aarti Drugs wins Pharmexcil Outstandin
Aarti Drugs has won Pharmexcil Outstanding Exports Award 2021-2022. The..

07Jul Aarti Drugs moves up on the BSE
Aarti Drugs is currently trading at Rs. 473.55, up by 3.25 points or 0.6..

02May Aarti Drugs informs about disclosure
Aarti Drugs has informed that it is not a Large Corporate as per the app..

28Feb Aarti Drugs informs about analyst meet
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligati..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	316.2	1528.1
Gross Profit	428.7	2048.1
Operating Profit	614.2	2846.3
Net Sales	5382.1	24979.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1455.20 (10.00%)	M.Cap ( in Cr)846.88
Solara Active Pharma (BSE) 551.45 (16.32%)	M.Cap ( in Cr)1985.01
Abbott India (BSE) 26131.85 (0.29%)	M.Cap ( in Cr)55528.36
Windlas Biotech (BSE) 555.05 (6.97%)	M.Cap ( in Cr)1154.42
Concord Biotech (BSE) 1595.25 (1.05%)	M.Cap ( in Cr)16688.90

Shareholding Pattern

	PROMOTERS	57.47%
	NON-INSTITUTION	35.17%
	MUTUAL FUNDS/UTI	5.18%
	FI/BANKS/INSURANCE	0.08%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund-Reg(G)	1.36
DSP Small Cap Fund-Reg(G)	1.27
DSP Value Fund-Reg(G)	0.38
Motilal Oswal S&P BSE Healthcare ETF	0.14
Groww Nifty Total Market Index Fund-Reg(G)	0.01
ICICI Pru S&P BSE 500 ETF	0.01
HDFC S&P BSE 500 Index Fund-Reg(G)	0.01

Investor Alert

1) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 2) For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors. 3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors. 4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. 5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. 6) This is to inform that we B N Rathi securities Ltd not required to have a Business Continuity/DR plan under the existing regulatory provisions.

ATTENTION INVESTORS | KYC | IPO

Prevent Unauthorised transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/DP. Receive information of your transactions directly from Exchanges/Depositories on your mobile/email at the end of the day. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account......Issued in the interest of investors. SEBI Circular - Investor Grievance Redress Mechanism - New Policy Measures. Kindly refer at Policies.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NOS: SEBI Registration No: INZ000160834 (BSE-3233 | NSE-07141| MCX-56475) CDSL : SEBI Regn No. IN-DP-612-2021. AMFI-Registered Mutual Fund Distributor: B.N.Rathi Securities Ltd - ARN-77516: (B.N.Rathi is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.) CIN: L65993TG1985PLC005838

GRIEVANCE CONTACT Investor Grievance Contact: investorgrievances@bnrsecurities.com | DP Investor Grievance: investorgrievances@bnrsecurities.com Investor Protection and Arbitration Exchange Circulars and Rules - NSE,BSE and MCX.

In case of member having a website, member has created awareness amongst clients / investors with regard to procedure of pledge/ re-pledge of securities and displayed the guidelines on the homepage of their respective websites at a prominent place as required in Exchange circular ref no. NSE/INSP/45565 dated Sep 02,2020 Trading members had displayed the set of standard documents/policies on their own website for information.

SEBI SCORES LETTER OF AUTHORITY BROKERS NORMS RMS POLICY PMLA-POLICY SURVEILLANCE POLICY KYC MANDATORY - 6 ATTRIBUTES EVoting CDSL EVoting NSDL

DISCLAIMER INACTIVE CLIENT POLICY PRIVACY POLICY TERMS & CONDITIONS COMPANY POLICIES INVESTOR GRIEVANCE REDRESSAL POLICY INVESTOR CHARTER INVESTOR CHARTER - DP INVESTOR CHARTER - RESEARCH ANALYST INVESTOR CHARTER IGC MIS ADVISORY FOR INVESTORS BNRSL-DISCLAIMERS RESEARCH REPORTS